Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5833248 | 0.83 | — | — | |
| SCHEMBL13265006 | 0.80 | — | — | |
| SCHEMBL19361146 | 0.80 | — | — | |
| SCHEMBL7682205 | 0.79 | TSHR (0.31) | TSHRHTT | |
| Hydrochloric Acid SCHEMBL3507717 | 0.78 | TSHR (0.33) | TSHRSLC7A5 | |
| SCHEMBL11669820 | 0.77 | TSHR (0.36) | TSHRHTTTP53 | |
| SCHEMBL1338978 | 0.77 | TSHR (0.50) | TSHRHTTTP53 | |
| SCHEMBL8636434 | 0.77 | TSHR (0.50) | TSHRHTTTP53 | |
| SCHEMBL1336756 | 0.77 | TSHR (0.50) | TSHRHTTTP53 | |
| SCHEMBL571478 | 0.77 | TSHR (0.50) | TSHRHTTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3938045-A1 | SALTS OF A ISOCHROMANYL COMPOUND AND CRYSTALLINE FORMS, PROCESSES FOR PREPARING, THERAPEUTIC USES, AND PHARMACEUTICAL COMPOSITIONS THEREOF | Sunovion Pharmaceuticals Inc. (US) | 2022-01-19 | — | — | EP | disclosed |
| WO-2020186165-A1 | SALTS OF A ISOCHROMANYL COMPOUND AND CRYSTALLINE FORMS, PROCESSES FOR PREPARING, THERAPEUTIC USES, AND PHARMACEUTICAL COMPOSITIONS THEREOF | SUNOVION PHARMACEUTICALS INC. (US) | 2020-09-17 | — | — | WO | disclosed |
| CN-105214450-A | A kind of selective absorbing SO 2absorbent and absorb SO 2process | HUANG RUI | 2016-01-06 | — | — | CN | disclosed |
| US-8258189-B2 | Compounds prepared by adding an oxetane derivative to an alcohol | CECALC (FR) | 2012-09-04 | — | — | US | disclosed |
| US-20100216894-A1 | NOVEL COMPOUNDS PREPARED BY ADDING AN OXETANE DERIVATIVE TO AN ALCOHOL | CECALC (FR) | 2010-08-26 | — | — | US | disclosed |
| US-6040372-A | Hydrated zinc stannate sols, coating compositions and optical elements | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2000-03-21 | — | — | US | disclosed |
| US-6001164-A | AS MICROFILLERS TO BE USED AS HARD COATING AGENT WITH HIGH REFRACTIVE INDEX TO BE APPLIED ON SURFACE OF PLASTIC LENSES, FILMS OR PLASTIC MOLDED PRODUCTS, OR MAY BE MIXED WITH VARIOUS RESIN EMULSIONS FOR USE AS FLAME RETARDANTS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1999-12-14 | — | — | US | disclosed |
| US-5891362-A | DISPERSED IN LIQUID | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1999-04-06 | — | — | US | disclosed |
| EP-0748768-A1 | Hydrated zinc stannate sols, coating compositions and optical elements | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1996-12-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216894-A1 | NOVEL COMPOUNDS PREPARED BY ADDING AN OXETANE DERIVATIVE TO AN ALCOHOL | ADH1A, ADH5, ADH1C | TSHR 4196/4885HTT 4727/4885SLC7A5 3801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.